As CCR4 is the shared receptor for both CCL17 and CCL22 and is reported to be overexpressed in tumor cells [28, 29], we next examined its expression on the membrane of CRC cells and reproducibly detected strong signals in the isolated membrane fractions (Fig. S4C). Here, CCL22 is linked to colorectal carcinoma.